Analysis of the Economic and Socio-Demographic Burden of HPV-Associated Diseases and the Cost-Effectiveness of HPV Vaccination in Russia
Background.The human papillomavirus (HPV) is one of the most common sexually transmitted viruses and, according to WHO, the cause of 7.5% of all women deaths from cancer. Every year, more than 500.000 new cases of HPV-associated cancer are registered in the world, approximately 90% of which fall int...
Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Union of pediatricians of Russia
2019-06-01
|
| Series: | Педиатрическая фармакология |
| Subjects: | |
| Online Access: | https://www.pedpharma.ru/jour/article/view/1723 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849695681721139200 |
|---|---|
| author | Alexander A. Baranov Alexander V. Plakida Leyla S. Namazova-Baranova Mikhail A. Semenov Olga V. Ilyushina Yevgeniy V. Guretskiy Marina V. Fedoseenko Alla V. Rudakova |
| author_facet | Alexander A. Baranov Alexander V. Plakida Leyla S. Namazova-Baranova Mikhail A. Semenov Olga V. Ilyushina Yevgeniy V. Guretskiy Marina V. Fedoseenko Alla V. Rudakova |
| author_sort | Alexander A. Baranov |
| collection | DOAJ |
| description | Background.The human papillomavirus (HPV) is one of the most common sexually transmitted viruses and, according to WHO, the cause of 7.5% of all women deaths from cancer. Every year, more than 500.000 new cases of HPV-associated cancer are registered in the world, approximately 90% of which fall into cervical cancer category. Aim. The aim of the work was to determine the economic and socio-demographic burden of HPV-associated diseases in Russia by analyzing the following indicators: fertility, life expectancy and cost of vaccines, as well as the impact of HPV vaccination. Methods. Mathematical modeling was performed using epidemiological data on prevalence and mortality of HPV-associated diseases in Russia, taking into account current data on the types of HPV-related diseases, the effectiveness of vaccination, statistics by sex and age structure of diseases, and age-specific birth rates. The calculations were based on 50% and 70% vaccination coverage, and the average life expectancy of 12-year-old girls. Treatment cost was calculated based on the fees charged by mandatory health insurance system. The weighted average cost of 1 dose of quadrivalent vaccine in 2018, and average cost of visiting a pediatrician before each vaccination were taken into account. To estimate the cost, a discount rate of 3.5% per year was used. The economic burden of HPV-associated diseases, direct and indirect medical costs were calculated. Results. The economic burden of HPV-associated diseases is estimated at 63.638 billion rubles. 70% vaccination rate would reduce the economic burden by 41.792 billion rubles, prevent 4,841 deaths from malignant neoplasms and reduce losses associated with a fall in the birth rate by 1,100 children per year. The estimated economic effect of vaccination per vaccinated girl will be 13,327 rubles, and the total economic effect over the entire simulation period will be 31.653 billion rubles. Conclusion. Taking into account the results of modeling, vaccination of 12-year-old girls against HPV in Russia is a cost-effective measure in the prevention of HPV-associated diseases. |
| format | Article |
| id | doaj-art-4f0253a4e84c4bc7aab6d539b71dbe11 |
| institution | DOAJ |
| issn | 1727-5776 2500-3089 |
| language | Russian |
| publishDate | 2019-06-01 |
| publisher | Union of pediatricians of Russia |
| record_format | Article |
| series | Педиатрическая фармакология |
| spelling | doaj-art-4f0253a4e84c4bc7aab6d539b71dbe112025-08-20T03:19:42ZrusUnion of pediatricians of RussiaПедиатрическая фармакология1727-57762500-30892019-06-0116210111010.15690/pf.v16i2.20071643Analysis of the Economic and Socio-Demographic Burden of HPV-Associated Diseases and the Cost-Effectiveness of HPV Vaccination in RussiaAlexander A. Baranov0Alexander V. Plakida1Leyla S. Namazova-Baranova2Mikhail A. Semenov3Olga V. Ilyushina4Yevgeniy V. Guretskiy5Marina V. Fedoseenko6Alla V. Rudakova7Central Clinical Hospital of the Russian Academy of SciencesAlliance Consulting JSC, ACIG Group of Companies; The Russian presidential academy of national economy and public administrationCentral Clinical Hospital of the Russian Academy of Sciences; Pirogov Russian National Research Medical UniversityAlliance Consulting JSC, ACIG Group of CompaniesAlliance Consulting JSC, ACIG Group of CompaniesAlliance Consulting JSC, ACIG Group of CompaniesPirogov Russian National Research Medical UniversityScientific Research Institute of Children's Infections; St. Petersburg Chemical Pharmaceutical AcademyBackground.The human papillomavirus (HPV) is one of the most common sexually transmitted viruses and, according to WHO, the cause of 7.5% of all women deaths from cancer. Every year, more than 500.000 new cases of HPV-associated cancer are registered in the world, approximately 90% of which fall into cervical cancer category. Aim. The aim of the work was to determine the economic and socio-demographic burden of HPV-associated diseases in Russia by analyzing the following indicators: fertility, life expectancy and cost of vaccines, as well as the impact of HPV vaccination. Methods. Mathematical modeling was performed using epidemiological data on prevalence and mortality of HPV-associated diseases in Russia, taking into account current data on the types of HPV-related diseases, the effectiveness of vaccination, statistics by sex and age structure of diseases, and age-specific birth rates. The calculations were based on 50% and 70% vaccination coverage, and the average life expectancy of 12-year-old girls. Treatment cost was calculated based on the fees charged by mandatory health insurance system. The weighted average cost of 1 dose of quadrivalent vaccine in 2018, and average cost of visiting a pediatrician before each vaccination were taken into account. To estimate the cost, a discount rate of 3.5% per year was used. The economic burden of HPV-associated diseases, direct and indirect medical costs were calculated. Results. The economic burden of HPV-associated diseases is estimated at 63.638 billion rubles. 70% vaccination rate would reduce the economic burden by 41.792 billion rubles, prevent 4,841 deaths from malignant neoplasms and reduce losses associated with a fall in the birth rate by 1,100 children per year. The estimated economic effect of vaccination per vaccinated girl will be 13,327 rubles, and the total economic effect over the entire simulation period will be 31.653 billion rubles. Conclusion. Taking into account the results of modeling, vaccination of 12-year-old girls against HPV in Russia is a cost-effective measure in the prevention of HPV-associated diseases.https://www.pedpharma.ru/jour/article/view/1723human papillomavirusvaccinationmalignant neoplasmscervical cancereconomic efficiencydisease burden |
| spellingShingle | Alexander A. Baranov Alexander V. Plakida Leyla S. Namazova-Baranova Mikhail A. Semenov Olga V. Ilyushina Yevgeniy V. Guretskiy Marina V. Fedoseenko Alla V. Rudakova Analysis of the Economic and Socio-Demographic Burden of HPV-Associated Diseases and the Cost-Effectiveness of HPV Vaccination in Russia Педиатрическая фармакология human papillomavirus vaccination malignant neoplasms cervical cancer economic efficiency disease burden |
| title | Analysis of the Economic and Socio-Demographic Burden of HPV-Associated Diseases and the Cost-Effectiveness of HPV Vaccination in Russia |
| title_full | Analysis of the Economic and Socio-Demographic Burden of HPV-Associated Diseases and the Cost-Effectiveness of HPV Vaccination in Russia |
| title_fullStr | Analysis of the Economic and Socio-Demographic Burden of HPV-Associated Diseases and the Cost-Effectiveness of HPV Vaccination in Russia |
| title_full_unstemmed | Analysis of the Economic and Socio-Demographic Burden of HPV-Associated Diseases and the Cost-Effectiveness of HPV Vaccination in Russia |
| title_short | Analysis of the Economic and Socio-Demographic Burden of HPV-Associated Diseases and the Cost-Effectiveness of HPV Vaccination in Russia |
| title_sort | analysis of the economic and socio demographic burden of hpv associated diseases and the cost effectiveness of hpv vaccination in russia |
| topic | human papillomavirus vaccination malignant neoplasms cervical cancer economic efficiency disease burden |
| url | https://www.pedpharma.ru/jour/article/view/1723 |
| work_keys_str_mv | AT alexanderabaranov analysisoftheeconomicandsociodemographicburdenofhpvassociateddiseasesandthecosteffectivenessofhpvvaccinationinrussia AT alexandervplakida analysisoftheeconomicandsociodemographicburdenofhpvassociateddiseasesandthecosteffectivenessofhpvvaccinationinrussia AT leylasnamazovabaranova analysisoftheeconomicandsociodemographicburdenofhpvassociateddiseasesandthecosteffectivenessofhpvvaccinationinrussia AT mikhailasemenov analysisoftheeconomicandsociodemographicburdenofhpvassociateddiseasesandthecosteffectivenessofhpvvaccinationinrussia AT olgavilyushina analysisoftheeconomicandsociodemographicburdenofhpvassociateddiseasesandthecosteffectivenessofhpvvaccinationinrussia AT yevgeniyvguretskiy analysisoftheeconomicandsociodemographicburdenofhpvassociateddiseasesandthecosteffectivenessofhpvvaccinationinrussia AT marinavfedoseenko analysisoftheeconomicandsociodemographicburdenofhpvassociateddiseasesandthecosteffectivenessofhpvvaccinationinrussia AT allavrudakova analysisoftheeconomicandsociodemographicburdenofhpvassociateddiseasesandthecosteffectivenessofhpvvaccinationinrussia |